Re‐transplantation after bortezomib‐based therapy
Curly Morris(Belfast Health and Social Care Trust), Jamie Cavenagh(St Bartholomew's Hospital), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Scott Marshall(South Tyneside and Sunderland NHS Foundation Trust), Gordon Cook(University of Leeds), Jim Cavet(University of Manchester), Mark Cook(Université Paris Cité), Jane Conn(Newcastle upon Tyne Hospital), Matthew Streetly(King's College - North Carolina), Paul Kettle(University of Ulster), Rakesh Popat(University College London Hospitals NHS Foundation Trust), John Ashcroft(Leeds Teaching Hospitals NHS Trust), Jane Tighe, Ade Olujohungbe(Aintree University Hospital), Mary Drake(University of Ulster), Michael Quinn(University of Ulster), Majit Kazmi(Guy's and St Thomas' NHS Foundation Trust), Heather Oakervee(Barts Health NHS Trust)
Cited by 8
Related Papers
Teclistamab in Relapsed or Refractory Multiple Myeloma
|New England Journal of Medicine|2022|1.2k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695